Admission to PLUS for DXS International

DXS International, a company which provides information publishing software and content solution services to healthcare professionals in the UK, has floated on PLUS.

Legal advice for the placing was provided by a team led by Philip Wild, partner at Kidd Rapinet. They advised on the admission document, and established the share structure for the various rounds of funding.

DXS International’s trading subsidiary, DXS (UK) provides a software package that gives up-to-date information to doctors, nurses and pharmacists about medical conditions, as well as currently available treatments, drugs, hospital and treatment centre facilities and capabilities.

The DXS service solution is installed at 20,000 GP practices, 14,000 retail pharmacies and in hospitals, where it is integrated into electronic patient record systems, enabling doctors to view the latest research relating to an individual patient’s medical condition, available treatments, and view the different drugs available, all during the patient encounter.

Marc Barber

Marc Barber

Marc was editor of GrowthBusiness from 2006 to 2010. He specialised in writing about entrepreneurs, private equity and venture capital, mid-market M&A, small caps and high-growth businesses.